As the pandemic showed, a one-size-fits-all approach is inadequate and it takes a targeted, community-informed strategy to improve public health responses, write Sonia Anand, Sujane Kandasamy and Upton Allen.
Diabetes trials are leaving out people who are most affected by diabetes.
The Future of Vaccinology Symposium was hosted by McMaster’s Global Nexus School for Pandemic Prevention & Response and the Michael G. DeGroote Institute for Infectious Disease Research.
McMaster logo
McMaster logo
